Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inclusion body myositis: clinical features and pathogenesis
Steven A. Greenberg
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 5, pp. 257-272
Closed Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Michael G. Hanna, Umesh A. Badrising, Olivier Benveniste, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 834-844
Open Access | Times Cited: 116
The ubiquitin–proteasome system in regulation of the skeletal muscle homeostasis and atrophy: from basic science to disorders
Yasuo Kitajima, Kiyoshi Yoshioka, Naoki Suzuki
The Journal of Physiological Sciences (2020) Vol. 70, Iss. 1
Open Access | Times Cited: 113
Classification of idiopathic inflammatory myopathies: pathology perspectives
Jantima Tanboon, Ichizo Nishino
Current Opinion in Neurology (2019) Vol. 32, Iss. 5, pp. 704-714
Closed Access | Times Cited: 104
Where are we moving in the classification of idiopathic inflammatory myopathies?
Jantima Tanboon, Akinori Uruha, Werner Stenzel, et al.
Current Opinion in Neurology (2020) Vol. 33, Iss. 5, pp. 590-603
Open Access | Times Cited: 97
The role of interferons type I, II and III in myositis: A review
L. Bolko, Wei Jiang, Nozomu Tawara, et al.
Brain Pathology (2021) Vol. 31, Iss. 3
Open Access | Times Cited: 69
Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis
Kyla A. Britson, Jonathan P. Ling, Kerstin E. Braunstein, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 628
Open Access | Times Cited: 50
Inclusion body myositis: Update on the diagnostic and therapeutic landscape
Elie Naddaf
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 38
Epidemiology of the idiopathic inflammatory myopathies
Thomas Khoo, James B Lilleker, Bernard Yu‐Hor Thong, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 11, pp. 695-712
Closed Access | Times Cited: 32
Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging
Tanes Lima, Pirkka‐Pekka Laurila, Martin Wohlwend, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Closed Access | Times Cited: 31
Idiopathic inflammatory myopathies: current insights and future frontiers
Caoilfhionn M Connolly, Latika Gupta, Manabu Fujimoto, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 2, pp. e115-e127
Open Access | Times Cited: 11
Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases
Christopher Nelke, Simone Schmid, Felix Kleefeld, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 9
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis
Sven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Nature Aging (2024) Vol. 4, Iss. 7, pp. 969-983
Open Access | Times Cited: 7
The unified myofibrillar matrix for force generation in muscle
T. Bradley Willingham, Yuho Kim, Eric Lindberg, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 53
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Buel D. Rodgers, Christopher W. Ward
Endocrine Reviews (2021) Vol. 43, Iss. 2, pp. 329-365
Open Access | Times Cited: 52
Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.

PubMed (2020) Vol. 39, Iss. 4, pp. 289-301
Closed Access | Times Cited: 51
Epidemiology and Natural History of Inclusion Body Myositis
Shahar Shelly, Michelle M. Mielke, Jay Mandrekar, et al.
Neurology (2021) Vol. 96, Iss. 21
Open Access | Times Cited: 43
256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021
Jan Damoiseaux, Andrew L. Mammen, Yves Piette, et al.
Neuromuscular Disorders (2022) Vol. 32, Iss. 7, pp. 594-608
Open Access | Times Cited: 32
Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells
Namita Goyal, Gérald Coulis, J.L. Duarte, et al.
Neurology (2022) Vol. 98, Iss. 13
Open Access | Times Cited: 31
Cellular senescence in neuroinflammatory disease: new therapies for old cells?
Christopher Nelke, Christina B. Schroeter, Marc Pawlitzki, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 10, pp. 850-863
Open Access | Times Cited: 29
Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis
Felix Kleefeld, Akinori Uruha, Anne Schänzer, et al.
Neurology (2022) Vol. 99, Iss. 20
Closed Access | Times Cited: 29
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro Machado, Michael McDermott, Thomas Blaettler, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 10, pp. 900-911
Open Access | Times Cited: 20
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Christopher Nelke, Christina B. Schroeter, Lukas Theissen, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 5, pp. 725-745
Open Access | Times Cited: 16
Multi-omics analysis in inclusion body myositis identifies mir-16 responsible for HLA overexpression
Daphne Wijnbergen, Mridul Johari, Ozan Özışık, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Assessment of muscle damage using magnetic resonance imaging data in dermatomyositis and sporadic inclusion body myositis
A. A. Kolomeychuk, L. P. Ananyeva, L. V. Ptichkina, et al.
Modern Rheumatology Journal (2025) Vol. 19, Iss. 1, pp. 12-19
Open Access
Spatial transcriptomics in autoimmune rheumatic disease: potential clinical applications and perspectives
Akira Miyamoto, Hiroshi Shimagami, Atsushi Kumanogoh, et al.
Inflammation and Regeneration (2025) Vol. 45, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top